All Stories

  1. Structure-guided approaches to modulate endosomal toll-like receptors TLR7, TLR8 and TLR9: advances, challenges and therapeutic promise
  2. Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins
  3. The monomeric but not homotrimeric spike protein of SARS-CoV-2 activates TLR4 signaling
  4. Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists
  5. The vasoconstrictor adenosine 5′-tetraphosphate is a danger signal that induces IL-1β
  6. Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
  7. Degrading the key component of the inflammasome: development of an NLRP3 PROTAC
  8. Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release
  9. Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
  10. Development of the First-in-Class Degrader of NLRP3
  11. Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling
  12. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  13. Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling
  14. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  15. P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
  16. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
  17. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  18. Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release
  19. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
  20. Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5
  21. Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
  22. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  23. Immunocompetent Human Intestinal Models in Preclinical Drug Development
  24. An update on endotoxin neutralization strategies in Gram-negative bacterial infections
  25. TatS: a novel in vitro tattooed human skin model for improved pigment toxicology research
  26. Biological Characterization, Mechanistic Investigation and Structure‐Activity Relationships of Chemically Stable TLR2 Antagonists
  27. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling
  28. Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells
  29. Identification and characterization of a novel chemotype for human TLR8 inhibitors
  30. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses
  31. Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis
  32. Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)
  33. Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening
  34. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5
  35. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo
  36. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
  37. Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization
  38. Glucocorticoids and Toll-like receptor 2 cooperatively induce acute-phase serum amyloid A
  39. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses
  40. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling
  41. Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues
  42. Recognition of Propionibacterium acnes by human TLR2 heterodimers
  43. Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration
  44. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells
  45. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement
  46. Erratum
  47. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  48. IL-4 abrogates T H 17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
  49. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cellsin vitro
  50. Regulation of Dendritic Cell Function in Inflammation
  51. Chloroquine Promotes IL-17 Production by CD4+T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells
  52. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility
  53. Core-multishell nanotransporters enhance skin penetration of the cell-penetrating peptide low molecular weight protamine
  54. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin
  55. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts
  56. Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders
  57. Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate
  58. 9 Mucosal Immunology in Candida albicans Infection
  59. Esterase activity in excised and reconstructed human skin – Biotransformation of prednicarbate and the model dye fluorescein diacetate
  60. Glycosylation of Candida albicans Cell Wall Proteins Is Critical for Induction of Innate Immune Responses and Apoptosis of Epithelial Cells
  61. Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors
  62. Interaction of the mucosal barrier with accessory immune cells during fungal infection
  63. 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles
  64. The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence
  65. Epithelial Cells and Innate Antifungal Defense
  66. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine againstTrichophyton rubrumin anin vitromodel of dermatophyte nail infection
  67. Influences of opioids and nanoparticles on in vitro wound healing models
  68. Models of Oral and Vaginal Candidiasis Based on In Vitro Reconstituted Human Epithelia for the Study of Host-Pathogen Interactions
  69. Introduction: Host Responses
  70. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection
  71. Charakterisierung der Interaktion zwischen Candida albicans und Wirtszellen
  72. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
  73. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
  74. Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin
  75. The Early Transcriptional Response of Human Granulocytes to Infection with Candida albicans Is Not Essential for Killing but Reflects Cellular Communications
  76. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia
  77. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
  78. In vivo Porphyrin Production by P. acnes in Untreated Acne Patients and its Modulation by Acne Treatment
  79. Receptor-Selective Retinoids for Psoriasis
  80. Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα
  81. Peroxisome Proliferator-Activated Receptors and their Ligands
  82. Induction of Nuclear Factor–κB and c‐Jun/Activator Protein–1 via Toll‐Like Receptor 2 in Macrophages by Antimycotic‐TreatedCandida albicans
  83. Hyaluronic Acid in the Treatment and Prevention of Skin Diseases: Molecular Biological, Pharmaceutical and Clinical Aspects
  84. Toll-like receptors as key mediators in innate antifungal immunity